Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
UBS
Mallinckrodt
Moodys
Medtronic
Cantor Fitzgerald
McKinsey
US Army

Generated: October 16, 2018

DrugPatentWatch Database Preview

Collegium Pharm Inc Company Profile

« Back to Dashboard

What is the competitive landscape for COLLEGIUM PHARM INC, and what generic alternatives to COLLEGIUM PHARM INC drugs are available?

COLLEGIUM PHARM INC has one approved drug.

There are fourteen US patents protecting COLLEGIUM PHARM INC drugs.

Summary for Collegium Pharm Inc
US Patents:14
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Collegium Pharm Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-005 Apr 26, 2016 RX Yes Yes 8,758,813 ➤ Try a Free Trial ➤ Try a Free Trial
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-005 Apr 26, 2016 RX Yes Yes 7,399,488 ➤ Try a Free Trial Y ➤ Try a Free Trial
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-005 Apr 26, 2016 RX Yes Yes 9,737,530 ➤ Try a Free Trial Y ➤ Try a Free Trial
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-005 Apr 26, 2016 RX Yes Yes 8,557,291 ➤ Try a Free Trial Y ➤ Try a Free Trial
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-002 Apr 26, 2016 RX Yes No 7,771,707 ➤ Try a Free Trial Y ➤ Try a Free Trial
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-003 Apr 26, 2016 RX Yes No 8,449,909 ➤ Try a Free Trial Y ➤ Try a Free Trial
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090-001 Apr 26, 2016 RX Yes No 7,771,707 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Collegium Pharm Inc Drugs

Country Document Number Estimated Expiration
European Patent Office 3326617 ➤ Try a Free Trial
Australia 2003247876 ➤ Try a Free Trial
Canada 2569958 ➤ Try a Free Trial
Japan 2015166402 ➤ Try a Free Trial
Poland 1765292 ➤ Try a Free Trial
Spain 2653568 ➤ Try a Free Trial
Japan 2006500426 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Collegium Pharm Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292 Luxembourg ➤ Try a Free Trial PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Argus Health
Daiichi Sankyo
Queensland Health
US Department of Justice
Julphar
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.